Seminars in Oncology
Volume 30, Issue 2 , Pages 107-109, April 2003

Defining Waldenstrom's macroglobulinemia☆☆☆

Department of Medical Oncology, Dana Farber Cancer Institute, and Department of Medicine, Harvard University, Boston, MA; University of Athens, Athens, Greece; and the Mayo Clinic, Rochester, MN.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Address reprint requests to Steven P. Treon, MD, MA, PhD, Waldenstrom's Macroglobulinemia Program, Dana Farber Cancer Institute, LG100, 44 Binney St, Boston, MA 02115.

☆☆ 0093-7754/03/3002-0046$30.00/0

PII: S0093-7754(03)70058-X

doi:10.1053/sonc.2003.50081

Seminars in Oncology
Volume 30, Issue 2 , Pages 107-109, April 2003

Article Tools

* Image Usage & Resolution